Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalyst Pharmaceuticals - 19 Year Stock Price History | CPRX

Historical daily share price chart and data for Catalyst Pharmaceuticals since 2006 adjusted for splits and dividends. The latest closing stock price for Catalyst Pharmaceuticals as of June 03, 2025 is 24.91.
  • The all-time high Catalyst Pharmaceuticals stock closing price was 25.74 on March 24, 2025.
  • The Catalyst Pharmaceuticals 52-week high stock price is 26.16, which is 5% above the current share price.
  • The Catalyst Pharmaceuticals 52-week low stock price is 14.75, which is 40.8% below the current share price.
  • The average Catalyst Pharmaceuticals stock price for the last 52 weeks is 20.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Catalyst Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 22.9763 21.5200 25.7400 19.5300 24.9100 19.36%
2024 17.7037 17.1100 23.9300 13.1800 20.8700 24.15%
2023 14.4758 18.0600 21.0500 11.5000 16.8100 -9.62%
2022 10.4443 6.9200 19.5000 5.3100 18.6000 174.74%
2021 5.3105 3.5300 7.4500 3.4500 6.7700 102.69%
2020 3.9635 3.7700 5.2100 2.6100 3.3400 -10.93%
2019 4.3321 2.1100 7.4300 2.1100 3.7500 95.31%
2018 3.0861 4.0100 4.0100 1.9200 1.9200 -50.90%
2017 2.3563 1.1300 4.4000 1.0900 3.9100 272.38%
2016 1.0943 2.3200 2.3600 0.5551 1.0500 -57.14%
2015 3.6925 2.9400 5.7400 2.3300 2.4500 -17.51%
2014 2.4007 2.1500 3.4200 1.7300 2.9700 52.31%
2013 1.2638 0.4430 3.3900 0.4300 1.9500 348.28%
2012 1.0501 1.3000 1.9900 0.3930 0.4350 -66.28%
2011 1.2816 1.1300 1.9300 0.9600 1.2900 30.30%
2010 1.0181 0.6100 2.0000 0.5550 0.9900 57.14%
2009 1.1935 2.2500 2.7500 0.4099 0.6300 -65.00%
2008 3.1467 3.4600 4.4400 1.3400 1.8000 -47.83%
2007 3.7359 4.5000 6.8300 2.5000 3.4500 -28.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.038B $0.492B
Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights to Firdapse (for treating LEMS) from BioMarin Pharmaceutical Inc. for its development and commercialization in the U.S. Firdapse is currently approved in the European Union and in the U.S. for treating of LEMS in adults. The company also plans to file a supplemental new drug application for Firdapse to treat pediatric patients with LEMS.?The company is also strengthening the commercial portfolio of Firdapse. It has already received multiple patents that cover the treatment of all amifampridine metabolizer types within the LEMS patient population.?Apart from Firdapse, the company is working on a generic version of Lundbeck's Sabril, CPP-109, for the treatment of infantile spasms and complex partial seizures.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.665B 32.14
Zoetis (ZTS) United States $75.819B 28.29
Daiichi Sankyo, - (DSNKY) Japan $49.559B 25.21
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Sandoz Group AG (SDZNY) Switzerland $22.493B 0.00
Merck (MKKGY) Germany $16.918B 12.40
Summit Therapeutics (SMMT) United States $15.314B 0.00
United Therapeutics (UTHR) United States $14.624B 12.94
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.371B 42.37
Orion OYJ (ORINY) Finland $9.913B 26.81
IPSEN (IPSEY) France $9.890B 0.00
Corcept Therapeutics (CORT) United States $7.371B 59.92
Stevanato Group S.p.A (STVN) Italy $6.599B 40.35
Madrigal Pharmaceuticals (MDGL) United States $6.315B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.734B 0.00
Ionis Pharmaceuticals (IONS) United States $5.532B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.900B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.006B 0.00
Hypermarcas (HYPMY) Brazil $2.829B 18.61
BioCryst Pharmaceuticals (BCRX) United States $2.342B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.335B 12.63
NewAmsterdam Pharma (NAMS) Netherlands $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.784B 0.00
Indivior (INDV) United States $1.748B 7.41
Dyne Therapeutics (DYN) United States $1.508B 0.00
Evotec AG (EVO) Germany $1.431B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Guardian Pharmacy Services (GRDN) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.081B 21.62
Harrow (HROW) United States $1.076B 0.00
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Ardelyx (ARDX) United States $0.940B 0.00
Collegium Pharmaceutical (COLL) United States $0.939B 5.07
Avadel Pharmaceuticals (AVDL) Ireland $0.912B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.727B 0.00
KalVista Pharmaceuticals (KALV) United States $0.664B 0.00
Xencor (XNCR) United States $0.651B 0.00
AleAnna (ANNA) United States $0.631B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Relay Therapeutics (RLAY) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.552B 0.00
Bioventus (BVS) United States $0.547B 13.88
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Tourmaline Bio (TRML) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Oruka Therapeutics (ORKA) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Altimmune (ALT) United States $0.440B 0.00
Verve Therapeutics (VERV) United States $0.431B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 9.85
Organogenesis (ORGO) United States $0.356B 0.00
Aquestive Therapeutics (AQST) United States $0.316B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.296B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.86
MediWound (MDWD) Israel $0.233B 0.00
ProKidney (PROK) United States $0.228B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.179B 0.00
Journey Medical (DERM) United States $0.168B 0.00
OmniAb (OABI) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Larimar Therapeutics (LRMR) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Liminatus Pharma (LIMN) $0.138B 0.00
Wellgistics Health (WGRX) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.089B 14.61
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 64.22
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Lyra Therapeutics (LYRA) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.14
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00